Department of Health

Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia: Bailie, Mason and Valaoras

The purpose of this study was to evaluate the shortterm safety and tolerability of a single dose of FCM (15 mg/kg; maximum of 1000 mg) over 15 minutes vs. placebo in a variety of populations with IDA.

Details

Topic
Research and reports
Date published
04 Jul 2013
Size
8 pages
Author
Department of Health & Human Services
Update frequency
Annual
Available format
PDF

Reviewed 05 July 2013

Was this page helpful?